2023-05-11 16:05:29 ET
- Miromatrix Medical press release ( NASDAQ: MIRO ): Q1 GAAP EPS of -$0.33 misses by $0.04 .
- Revenue of $7.98M (+17.9% Y/Y).
For further details see:
Miromatrix Medical GAAP EPS of -$0.33 misses by $0.04, revenue of $7.98M2023-05-11 16:05:29 ET
For further details see:
Miromatrix Medical GAAP EPS of -$0.33 misses by $0.04, revenue of $7.98MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Miromatrix Medical Inc. Company Name:
MIRO Stock Symbol:
Market:
United Therapeutics Corporation (Nasdaq: UTHR ) and Miromatrix Medical Inc. (Nasdaq: MIRO ) announced today that United Therapeutics, through its wholly owned subsidiary Morpheus Subsidiary Inc. (“ Merger Sub ”), has successfully completed the previously announced tender...
United Therapeutics Corporation (Nasdaq: UTHR ) and Miromatrix Medical Inc. (Nasdaq: MIRO ) announced today the results of the previously announced tender offer by Morpheus Subsidiary Inc. (“ Merger Sub ”), a wholly owned subsidiary of United Therapeutics, to acquire all...
NEW YORK, NY / ACCESSWIRE / November 18, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: CapStar Financial Holdings, Inc. ...